In addition, miR-144 could inhibit human hepatocellular carcinoma by regulating CCNB1 [43], repress the mTOR-VEGF pathway by targeting SGK3 in HCC [44], and reverse the chemoresistance of HCC cells by suppressing Nrf2 [45]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.